Clinical trial
Probiotics for the Prevention of Major Complications of Cirrhosis
NCT00312910 · Meir Medical Center, Other · Completed
Key facts
| NCT number | NCT00312910 |
|---|---|
| Title | Probiotics for the Prevention of Major Complications of Cirrhosis |
| Official title | Probiotics for the Prevention of Major Complications of Cirrhosis |
| Lead sponsor | Meir Medical Center, Other |
| Collaborators | Ambrosia - SupHerb Ltd. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Liver Cirrhosis |
| Intervention type | Drug |
| Interventions | Probiotics-Bio-plus |
| Enrollment | 50 |
| Start date | Apr 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Apr 11, 2006 |
| Last update posted | May 22, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: